Forschungs- & Entwicklungsinformationsdienst der Gemeinschaft - CORDIS

FP7

DAVIAD

Project reference: 602779
Funded under

The development of a novel therapeutic vaccine for the selective treatment of the autoimmune disorder, Graves’ disease

From 2013-12-01 to 2017-11-30, ongoing project

Project details

Total cost:

EUR 8 353 437,67

EU contribution:

EUR 5 924 893

Coordinated in:

Belgium

Call for proposal:

FP7-HEALTH-2013-INNOVATION-1See other projects for this call

Funding scheme:

CP-FP - Small or medium-scale focused research project

Objective

Related information

Coordinator

APITOPE INTERNATIONAL NV
Belgium

EU contribution: EUR 4 066 242,66


AGORALAAN A BIS
3590 DIEPENBEEK
Belgium
Administrative contact: Luc Lammens
Tel.: +32 499 52 54 52
Fax: +32 11 28 69 09
E-mail

Participants

QUINTILES BENEFIT FRANCE INC
France

EU contribution: EUR 885 609


RUE MAURICE RAVEL 3/5
92594 LEVALLOIS PERRET CEDEX
France
Administrative contact: Gary Johnson
Tel.: +33 450449465
Fax: +33 450449465
E-mail
KWS BIOTEST LIMITED
United Kingdom

EU contribution: EUR 958 280,34


BOWER MOUNT ROAD 34
ME16 8AU MAIDSTONE KENT
United Kingdom
Administrative contact: Neil Williams
Tel.: +44 1179287886
Fax: +44 1179287896
E-mail
GlaxoSmithKline Biologicals S.A
Participation ended
Belgium

EU contribution: EUR 14 761


Rue de l’Institut
1330 Rixensart
Belgium
Administrative contact: Philippe Denoel
Tel.: +3226564032
E-mail

Subjects

Life Sciences
Record Number: 110669 / Last updated on: 2015-11-23